<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>건강과 대안 &#187; 아스트라-제네카(Astra-Zeneca)</title>
	<atom:link href="http://www.chsc.or.kr/tag/%EC%95%84%EC%8A%A4%ED%8A%B8%EB%9D%BC-%EC%A0%9C%EB%84%A4%EC%B9%B4%28Astra-Zeneca%29/feed" rel="self" type="application/rss+xml" />
	<link>http://www.chsc.or.kr</link>
	<description>연구공동체</description>
	<lastBuildDate>Mon, 13 Apr 2026 01:34:28 +0000</lastBuildDate>
	<language>ko-KR</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.2</generator>
		<item>
		<title>[돼지독감] WHO 또다시 돼지독감 리베이트 스캔들에 휘말려</title>
		<link>http://www.chsc.or.kr/?post_type=reference&#038;p=2074</link>
		<comments>http://www.chsc.or.kr/?post_type=reference&#038;p=2074#comments</comments>
		<pubDate>Tue, 29 Jun 2010 18:31:34 +0000</pubDate>
		<dc:creator>건강과대안</dc:creator>
				<category><![CDATA[식품 · 의약품]]></category>
		<category><![CDATA[CSL Ltd]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[WHO 리베이트]]></category>
		<category><![CDATA[가짜 대유행 스캔들]]></category>
		<category><![CDATA[노바티스(Novartis)]]></category>
		<category><![CDATA[돼지독감]]></category>
		<category><![CDATA[로슈]]></category>
		<category><![CDATA[사노피-아벤티스(Sanofi-Aventis)]]></category>
		<category><![CDATA[신종플루]]></category>
		<category><![CDATA[아스트라-제네카(Astra-Zeneca)]]></category>
		<category><![CDATA[유럽의회]]></category>

		<guid isPermaLink="false">http://www.chsc.or.kr/?post_type=reference&#038;p=2074</guid>
		<description><![CDATA[세계보건기구(WHO)가 신종플루(돼지독감) 대유행과 관련하여 제약업계로부터 리베이트를 받은 혐의로 스캔들에 휘말렸다는 소식입니다.WHO의 신종플루 대유행 스캔들로 인하여 호주의 제약회사&#160;CSL, Ltd,&#160;사노피-아벤티스(Sanofi-Aventis),&#160;아스트라-제네카(Astra-Zeneca),&#160;노바티스(Novartis) 등 백신제조회사들은 수조달러가 넘는 막대한 이익을 남겼습니다.뿐만 아니라&#160;타미플루를 생산하는 로슈, [...]]]></description>
				<content:encoded><![CDATA[<p><P>세계보건기구(WHO)가 신종플루(돼지독감) 대유행과 관련하여 제약업계로부터 리베이트를 받은 혐의로 스캔들에 휘말렸다는 소식입니다.<BR><BR>WHO의 신종플루 대유행 스캔들로 인하여 호주의 제약회사&nbsp;CSL, Ltd,&nbsp;사노피-아벤티스(Sanofi-Aventis),&nbsp;아스트라-제네카(Astra-Zeneca),&nbsp;노바티스(Novartis) 등 백신제조회사들은 수조달러가 넘는 막대한 이익을 남겼습니다.<BR><BR>뿐만 아니라&nbsp;타미플루를 생산하는 로슈, 릴렌자를 생산하는 GSK 등 항바이러스제 생산 제약회사들도 엄청난 수익을 올렸습니다.<BR><BR>최근 유럽의회는 &#8220;WHO가 H1N1 대유행을 선언한 방식에 따라 막대한 공공 기금이 소모되었으며, 유럽 시민들이 직면한 건강상 위험에 대한 공황과 공포는 근거가 없는 것이었다&#8221;는 결론을 내렸다고 합니다.<BR><BR>==========================================================<BR><BR></P><br />
<P class=formatpublished minmax_bound="true">News</P><br />
<H1 class="heading entry-title" minmax_bound="true">Flu experts rebut conflict claims</H1><br />
<P class=intro minmax_bound="true">Reports throw unsubstantiated suspicion on scientific advice given to the World Health Organization.</P><br />
<P class=byline minmax_bound="true" sizset="21" sizcache="45"><SPAN class=vcard minmax_bound="true" sizset="21" sizcache="45"><SPAN class="author fn" minmax_bound="true" sizset="21" sizcache="45"><A href="http://www.nature.com/news/author/Declan+Butler/index.html" minmax_bound="true">Declan Butler</A> <BR><BR>출처 : Published online <ABBR class=published title=2010-06-08T14:30:00Z minmax_bound="true">8 June 2010</ABBR> | <SPAN class=journalname minmax_bound="true">Nature</SPAN> <SPAN class=journalnumber minmax_bound="true">465</SPAN>, 672-673 (2010) | doi:10.1038/465672a<BR><A href="http://www.nature.com/news/2010/100608/full/465672a.html?s=news_rss">http://www.nature.com/news/2010/100608/full/465672a.html?s=news_rss</A><BR><BR></SPAN></SPAN></P><br />
<P minmax_bound="true">&#8220;Drug firms &#8216;encouraged world health body to exaggerate swine flu threat&#8217;,&#8221; screamed Britain&#8217;s <SPAN class=i minmax_bound="true">Daily Mail </SPAN>newspaper on 4 June. &#8220;2 European reports criticize WHO&#8217;s H1N1 pandemic guidelines as tainted,&#8221; headlined <SPAN class=i minmax_bound="true">The Washington Post </SPAN>the next day. To judge from media coverage last week, a major scandal had been exposed in the handling of the H1N1 flu pandemic by the World Health Organization (WHO). But nothing could be further from the truth. </P><br />
<P minmax_bound="true">The news articles reported on two investigations: one by journalists at the <SPAN class=i minmax_bound="true">BMJ </SPAN>and the Bureau of Investigative Journalism, a non-profit body in London launched in April; the other by the health committee of the Parliamentary Assembly of the Council of Europe (PACE) — a human-rights body based in Strasbourg, France, independent of the European Union. </P><br />
<P minmax_bound="true">Both reports allege that the WHO might have been unduly influenced by the pharmaceutical industry in declaring H1N1 flu a pandemic, and in backing widespread vaccination and stockpiling of antiviral drugs, a claim often made by conspiracy theorists. They also complain that a 2004 WHO pandemic-preparedness document did not reveal that some of its authors had been paid for work by pharmaceutical companies — although the scientists had declared their competing interests elsewhere. </P><br />
<H2 class=inlineheading minmax_bound="true">Suspicious minds</H2><br />
<P minmax_bound="true" sizset="22" sizcache="45">Paul Flynn, a UK Labour Member of Parliament and rapporteur of the PACE report (see <A href="http://go.nature.com/G9CvVL" minmax_bound="true">go.nature.com/G9CvVL</A>), and Fiona Godlee, editor-in-chief of the <SPAN class=i minmax_bound="true">BMJ</SPAN>, presented their reports at a press conference together in Paris on 4 June, with Flynn asserting that &#8220;this was a pandemic that never really was&#8221;. Afterwards, he wrote on his blog: &#8220;One of the joys today was giving evidence with the editor of the splendid British Medical Journal. We have never met before but we cooed in harmony and just avoided saying it was the Pharmas that did it.&#8221;</P><br />
<P minmax_bound="true">Both reports say that it is suspicious, for example, that the WHO has kept secret the names of its Emergency Committee, an expert group that advises the WHO on the status of international public-health emergencies, including the declaration of a flu pandemic. Gregory Hartl, a spokesman for the WHO, says that the secrecy of the Emergency Committee&#8217;s membership is maintained to buffer its deliberations from outside pressure. The WHO says that it will make public the names, and any competing interests, once the pandemic is declared over. </P><br />
<P minmax_bound="true" sizset="23" sizcache="45">&#8220;A key question will be whether the pharmaceutical companies, which had invested around $4 bn (£2.8bn, €3.3bn) in developing the swine flu vaccine, had supporters inside the emergency committee, who then put pressure on WHO to declare a pandemic,&#8221; says the article in the <SPAN class=i minmax_bound="true">BMJ </SPAN>(<A href="http://dx.doi.org/10.1136/bmj.c2912" minmax_bound="true">D. Cohen and P. Carter <SPAN class=i minmax_bound="true">Br. Med. J. </SPAN><B minmax_bound="true">340, </B>c2912; 2010</A>). &#8220;It was the declaring of the pandemic that triggered the contracts.&#8221;</P><br />
<P minmax_bound="true">This is false. Many countries — including the United Kingdom, France, Belgium, Finland, Canada, the Netherlands and Switzerland — had already placed large orders for H1N1 vaccine weeks before the WHO declared H1N1 a pandemic on 11 June 2009. The United States, for example, ordered US$649 million of pandemic H1N1 influenza vaccine antigen and $283 million of adjuvant on 22 May 2009. So the Emergency Committee could not have influenced these in any way.</P><br />
<P minmax_bound="true">&#8220;You are absolutely right,&#8221; conceded the authors of the articles in the <SPAN class=i minmax_bound="true">BMJ </SPAN>when challenged with this timeline. </P><br />
<P minmax_bound="true">Both reports also seize on the WHO&#8217;s April 2009 revision of its criteria on what constitutes a pandemic, which removed the need for an assessment of the &#8216;severity&#8217; of the disease, based on estimates of future mortality. Flynn speculated in the <SPAN class=i minmax_bound="true">Daily Mail </SPAN>that this was suspicious: &#8220;In this case, it might not just be a conspiracy theory, it might be a very profitable conspiracy.&#8221; Neither report provides any evidence to substantiate its implication that the WHO rushed to declare a pandemic to boost pharmaceutical company sales. Moreover, the WHO says that the revisions were finalized in February 2009, before pandemic H1N1 was on the horizon.</P><br />
<P minmax_bound="true">Scientists interviewed by <SPAN class=i minmax_bound="true">Nature </SPAN>early on in the pandemic noted that severity is impossible to pin down until many months after it starts. Also, pandemic viruses can mutate or reassort to become more severe, so initial estimates are in any case of limited use. </P><br />
<H2 class=inlineheading minmax_bound="true">Clear firewall</H2><br />
<P minmax_bound="true">The <SPAN class=i minmax_bound="true">BMJ </SPAN>also notes that three scientists who were involved in the preparation of a 2004 WHO document, <SPAN class=i minmax_bound="true">WHO Guidelines on the Use of Vaccines and Antivirals during Influenza Pandemics</SPAN>, had received payments from pharmaceutical companies, including research funding, or consultancy or speaker fees. The scientists told the <SPAN class=i minmax_bound="true">BMJ </SPAN>that they had declared these competing interests to the WHO, although the WHO had not included these in its report.</P><br />
<P minmax_bound="true">Michael Osterholm, director of the University of Minnesota&#8217;s Center for Infectious Disease Research and Policy in Minneapolis, points out that the 2004 document was based on input from an international panel of 22 scientists and public-health officials, in response to the threat of the deadly H5N1 avian flu virus. &#8220;To suggest that the three scientists were able to direct and control the final recommendations is naive, and stated without a single shred of evidence,&#8221; he says. </P><br />
<P minmax_bound="true">The <SPAN class=i minmax_bound="true">BMJ </SPAN>also claims that industry funding of the European Scientific Working Group on Influenza (ESWI), a group of flu scientists that provided advice to the WHO, presented a &#8220;potential conflict of interest&#8221;. It notes that several ESWI scientists also receive industry funding directly.</P><br />
<P minmax_bound="true">One of those scientists is Albert Osterhaus, a virologist at Erasmus Medical Centre in Rotterdam in the Netherlands, who chairs the ESWI. He says that the body has a &#8220;clear firewall&#8221; with its funders, and that it informs all partners about any of its competing interests — its sources of funding are also listed on its website. Private–public partnerships are essential in tackling pandemics, and excluding flu researchers with industry links would deprive advisory panels of world-class expertise, he says. &#8220;The critical thing is transparency,&#8221; says Osterhaus. &#8220;I have always declared my own competing interests.&#8221;</P><!-- 300x250 ad --><br />
<P minmax_bound="true">The <SPAN class=i minmax_bound="true">BMJ </SPAN>acknowledges that the researchers had declared their interests elsewhere. But it takes issue with the WHO&#8217;s not having included them in its pandemic-planning documents. </P><br />
<P minmax_bound="true">David Ozonoff, an epidemiologist at the Boston University School of Public Health in Massachusetts, says that the reports &#8220;smear&#8221; the scientists involved in pandemic planning by &#8220;insinuating&#8221; that they would have offered different advice had they not had a relationship with drug companies. &#8220;This is a pretty serious charge,&#8221; he says.</P><br />
<P minmax_bound="true">&#8220;We think this is the researcher&#8217;s reading into it, not necessarily ours,&#8221; the BMJ authors respond. </P><br />
<P minmax_bound="true">Marc Lipsitch, an epidemiologist at Harvard School of Public Health in Boston, Massachusetts, says that the WHO&#8217;s advice on the pandemic has been sound, and has reflected the state of scientific opinion. Comparing the situation with the ongoing Deepwater Horizon oil spill, Lipsitch says that &#8220;it is ironic, as we watch for the second time in five years the catastrophic results of &#8216;best-case scenario planning&#8217; in the Gulf of Mexico, to have the WHO coming under criticism for planning for, and raising awareness of, the possibility of a severe pandemic. That is what public-health agencies should do, and what most did in this instance, and they should be commended for it.&#8221;<SPAN class=end-of-item minmax_bound="true">&nbsp;</SPAN></P><br />
<P class=byline minmax_bound="true" sizset="21" sizcache="45"><FONT size=3><STRONG>==========================<BR><BR>World Health Organization embroiled in swine flu kickback scandal</STRONG></FONT> <BR><BR>출처 : <A href="http://www.huliq.com/9990/world-health-organization-embroiled-swine-flu-kickback-scandal">http://www.huliq.com/9990/world-health-organization-embroiled-swine-flu-kickback-scandal</A><BR><BR>The World Health Organization (WHO) is again in the spotlight and being accused of accepting kickbacks from the pharmaceutical industry. In return for monetary compensation, the WHO had to issue an H1N1 or “swine flu” pandemic worldwide.</P><br />
<P lastVisited="0" roundtrip="0">The Health Advisory Board of the WHO made the decision to issue a worldwide statement, declaring the H1N1 threat a pandemic and encouraging countries to stockpile vaccines to protect the population from contact or aerosol contamination.</P><br />
<P lastVisited="0" roundtrip="0">The vaccine, available since 2009, is made by CSL, Ltd, Melbourne, Sanofi-Aventis, Paris, Astra-Zeneca, London and Novartis, Basel. All companies promised financial kickbacks after a pandemic was officially declared by the WHO resulting in multi billion dollar gains for the pharmaceutical companies.</P><br />
<P lastVisited="0" roundtrip="0">The scheme was first reported by the British Medical Journal in 2009 and later confirmed by the Bureau of Investigative Journalism but did not receive a lot of exposure until yesterday when the Council of Europe Parliamentary Assembly (PACE) endorsed the conclusions of its Health Committee.</P><br />
<P lastVisited="0" roundtrip="0">The conclusions from the committee stated that “the handling by the WHO of the H1N1 pandemic led to a waste of large sums of public money and unjustified scares and fears about health risks faced by the European public”.</P><br />
<P lastVisited="0" roundtrip="0">The scheme, as set up by the WHO’s Health Advisory Board was a five step process. First they exaggerated the risk, they urged countries to stockpile, vaccine producers collected the cash, the board members cashed in the kickbacks and the WHO kept everybody afraid.</P><br />
<P lastVisited="0" roundtrip="0">Secretary General of the WHO, Dr. Margaret Chan, was asked to release the names of all the members of her advisory board but insisted that the secrecy was crucial to protect the integrity and independence of the work the board members perform.</P><br />
<P lastVisited="0" roundtrip="0">The pharmaceutical industry has a very big influence on the World Health Organization, an independent UN agency, whose reputation has been tarnished in light of the scandal.</P><br />
<P lastVisited="0" roundtrip="0">Written by Nick Doms © 2010, all rights reserved</P><br />
<DIV class=node-submitted lastVisited="2" roundtrip="0">Submitted by <A title="View user profile." href="http://www.huliq.com/user/nick-doms" lastVisited="0" roundtrip="0" jQuery1277798925515="25">Nick Doms</A> on 2010-06-25<BR><BR>===================<BR><BR><br />
<H2><A class=entry-title title='"신종플루 전문가, 제약회사와 유착"' href="http://doc3.koreahealthlog.com/38956" rel=bookmark><FONT color=#000000 size=4>&#8220;신종플루 전문가, 제약회사와 유착&#8221;</FONT></A></H2><br />
<DIV class=author><A class=categoryBtn href="http://doc3.koreahealthlog.com/category/%EC%9D%98%EB%A3%8C%EA%B3%84%20%EB%89%B4%EC%8A%A4/%EC%A0%9C%EC%95%BD%2C%EC%9D%98%EB%A3%8C%EC%82%B0%EC%97%85"><FONT color=#777777>의료계 뉴스/제약,의료산업</FONT></A> <SPAN class=date><FONT face=Tahoma color=#aaaaaa size=1>2010/06/04 14:00</FONT></SPAN> <BR><BR><BR><SPAN class=Apple-style-span style="WORD-SPACING: 0px; FONT: medium Gulim; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); TEXT-INDENT: 0px; WHITE-SPACE: normal; LETTER-SPACING: normal; BORDER-COLLAPSE: separate; orphans: 2; widows: 2; webkit-border-horizontal-spacing: 0px; webkit-border-vertical-spacing: 0px; webkit-text-decorations-in-effect: none; webkit-text-size-adjust: auto; webkit-text-stroke-width: 0px"><SPAN class=Apple-style-span style="FONT-SIZE: 15px; COLOR: rgb(47,47,47); LINE-HEIGHT: 22px; FONT-FAMILY: 굴림, gulim, sans-serif; TEXT-ALIGN: left">지난 2004년 신종플루 관련 세계보건기구(WHO) 가이드라인 작성에 참여한 과학자 세명이 대형 제약업체들로부터 이전에 돈을 받은 적이 있었다는 내용의 보고서를 유럽의회가 4일 발표했다고 영국 일간 가디언 인터넷판이 보도했다.<BR><BR>&nbsp;&nbsp; 브리티시 메디컬 저널(BMJ)과 비영리조사단체인 언론조사국(BIJ) 공동 조사에서 WHO 가이드라인의 저자인 프레드 하이든, 아널드 몬토, 칼 니컬슨 등은 타미플루 제조사인 로슈와 레렌자 제조사인 글락소스미스클라인(GSK)으로부터 다른 사안으로 돈을 지급받은 일이 있는 것으로 드러났다.<BR><BR>&nbsp;&nbsp; 하이든 교수는 가이드라인이 작성되고 발표된 시점에 로슈로부터 강의료와 자문료를 받았고 2002년까지 GSK로부터 역시 자문료와 강의료를 받았다고 인정했다. 그 전해에는 로슈가 스폰서가 된 타미플루 판매 관련 연구에서 주저자들 중 한사람이었다.<BR><BR>&nbsp;&nbsp; 몬토 박사는 대유행의 시기에 백신 사용문제를 다룬 WHO 부칙의 주저자로, 로슈와 GSK로부터 자문료와 연구지원을 받았다고 밝혔다.<BR><BR>&nbsp;&nbsp; 니컬슨 교수는 인플루엔자 대유행에 관한 연구로 잘 알려져있는데 GSK와 로슈로부터 후원을 받았다고 시인했다.<BR><BR>&nbsp;&nbsp; 이 WHO 가이드라인은 신종플루 유행에 대비해 항바이러스제를 비축하라는 내용으로 되어있다.<BR><BR>&nbsp;&nbsp; 영국을 포함한 많은 국가가 이 가이드라인을 받아들여 타미플루를 대량으로 사들였다.<BR><BR>&nbsp;&nbsp; 각국 정부가 항바이러스제를 사들임에 따라 이 제약업체들은 70억달러 이상의 수입을 올렸다.<BR><BR>&nbsp;&nbsp; 영국은 6만5천명이 바이러스로 사망할 수 있다고 경고하고 항바이러스제와 백신을 사들이는데 10억파운드를 쓴 것으로 추정된다.<BR><BR>&nbsp;&nbsp; 그러나 폴란드 같은 일부 국가들은 지난해 WHO가 신종플루의 대유행을 선언했을 때 촉발된 패닉에 가까운 백신과 항바이러스제 구매 행렬에 참가하지 않았다.<BR><BR>&nbsp;&nbsp; 유럽의회 보건위원회의 폴 플라인 의원(노동당)은 &#8220;제약업체의 영향력이 의사결정과정의 모든 수준에 행사됐다&#8221;라고 주장하고 &#8220;전 유럽에 걸쳐 공중보건서비스의 우선순위에 왜곡이 있었고 막대한 공적 자금이 낭비됐으며 부당한 공포를 유발했다는 점에서 WHO는 투명해야 한다&#8221;라고 강조했다.<BR><BR>&nbsp;&nbsp; 지난해 신종플루가 대대적으로 유행할 것이라는 예측이 현실화되지 않으면서 투명성 문제가 제기됐다.<BR><BR>&nbsp;&nbsp; 영국 국무조정실은 약품 구입에 납세자들이 부담한 비용에 대한 조사에 착수했다.<BR></SPAN></SPAN></DIV></DIV></p>
]]></content:encoded>
			<wfw:commentRss>http://www.chsc.or.kr/?post_type=reference&#038;p=2074/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
